Related Experiment Videos
Identification of new dinucleotide-repeat polymorphisms in factor VIII gene using fluorescent PCR
1Laboratory of Medical Genetics, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University, Seoul, Korea.
Summary
This study introduces two new intragenic markers for the Factor VIII gene, improving carrier detection and prenatal diagnosis for Haemophilia A. These markers enhance diagnostic accuracy in families affected by this X-linked bleeding disorder.
Area of Science:
- Genetics
- Molecular Biology
- Medical Diagnostics
Background:
- Haemophilia A is an X-linked inherited bleeding disorder.
- Linkage analysis using polymorphic markers in the Factor VIII (FVIII) gene is crucial for carrier detection and prenatal diagnosis.
- Existing markers may have limitations in diagnostic efficiency.
Purpose of the Study:
- To establish the allele frequency and heterozygosity rate (HR) of two novel intragenic FVIII markers (Intron 1 and Intron 24).
- To evaluate the utility of these new markers alongside existing ones (Intron 13 and 22) for carrier detection and prenatal diagnosis.
- To assess the combined diagnostic power of multiple intragenic markers.
Main Methods:
- Fluorescent polymerase chain reaction (PCR) was employed to analyze five hundred unrelated healthy women and a haemophilic family.
- Allele frequencies and heterozygosity rates (HR) were calculated for four intragenic FVIII markers: Intron 1, Intron 24, Intron 13, and Intron 22.
- Carrier detection and prenatal diagnosis were performed using a combination of intragenic and extragenic markers, including AMXY PCR and chromosome analysis.
Main Results:
- Five, ten, nine, and six alleles were observed for Intron 1, Intron 24, Intron 13, and Intron 22, respectively.
- Observed HRs were 34.0%, 35.2%, 53.0%, and 42.6% for Intron 1, 24, 13, and 22, closely matching expected rates.
- The combined use of all four intragenic markers achieved a high heterozygosity rate of 76.6% (383/500).
- A case study demonstrated successful prenatal diagnosis in a haemophilic family, identifying a male fetus as normal.
Conclusions:
- The two newly established intragenic markers (Intron 1 and 24) are valuable additions for FVIII gene analysis.
- These markers, particularly when combined, significantly enhance the accuracy and efficiency of carrier detection and prenatal diagnosis for Haemophilia A.
- The study confirms the utility of these markers in real-world diagnostic scenarios for affected families.